김소연 (서울아산병원)님 | 한빛사연구자 > 한빛사

서울아산병원

최종업데이트 2020.04.01.

[Letter to the Editor]Selection of MRI contrast agent and diagnostic criteria for HCC to maximize the advantages of contrast agents
- J. Hepatol., Available online 13 June 2020 | https://doi.org/10.1016/j.jhep.2020.04.007
- 2020-06
- 의약학
- 한빛사논문
Reply to: “Non-enhanced magnetic resonance as a surveillance tool for hepatocellular carcinoma: Many unresolved issues”
- J. Hepatol., Available online 27 March 2020 | https://doi.org/10.1016/j.jhep.2020.03.004
- 2020-03
- 의약학
- 한빛사논문
Non-enhanced Magnetic Resonance Imaging as a Surveillance Tool for Hepatocellular Carcinoma: Comparison with Ultrasound
- J. Hepatol., Available online 10 December 2019 | https://doi.org/10.1016/j.jhep.2019.12.001
- 2019-12
- 의약학
- 한빛사논문
MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma
- JAMA Oncol., April 2017; 3(4):456-463 | doi:10.1001/jamaoncol.2016.3147
- 2017-04
- 의약학
- 한빛사논문
Pre-treatment Estimation of Future Remnant Liver Function using Gadoxetic acid MRI in Patients with HCC
- J. Hepatol., Available online 28 July 2016 | doi:10.1016/j.jhep.2016.07.024
- 2016-07
- 한빛사논문

연구자 ID

저자논문